Sign Up

Your Profile will be reviewed by Admin
Feb 2018


Marriott Marquis Houston 1777 Walker Street Houston , Texas 77010
Tel: (713) 654-1777
Google Map

SPIE Medical Imaging 2018






$415 - $875


Event Overview:

The conference where the latest information is presented by leading physicists, researchers, and scientists in image processing, perception, registration informatics, and segmentation, as well as digital pathology, tomography, computer-aided diagnosis, and ultrasound. 

Make plans to join your colleagues in Texas.

Attendee Information:

Join your colleagues and hear over 900 papers, across 9 conferences

Attend and listen at the conference that focuses on the latest innovations related to underlying fundamental scientific principles, technology developments, scientific evaluation, and clinical applications.

It all happens in Houston

Why medical imaging is at home in Texas:

Houston – City of Possibilities – is rich in medical research and advances directly affecting the applications of imaging, wearable sensors, deep learning, precision medicine, digital pathology and more.

This area offers one of the highest densities of clinical facilities for patient care, basic science, and translational research and continues to be a hub for medical advancement and care thanks to the proximity of the Texas Medical Center, MD Anderson Cancer Center, Rice University and the University of Houston; top level research in one location. Join your colleagues in Houston and network with like-minded leaders gathering in one city.

Exhibitor / Sponsor Information:

Maximize your visibility to the medical imaging community; secure a sponsorship for SPIE Medical Imaging 2018.


Reach over 1,200 attendees


Leverage opportunities that span six days of conferences

A variety of sponsorship options to reach your target audience


Corporate Sponsor


Career Recruitment Sponsor


Basic Table Top


Conference Sponsorships


Event Specific Sponsorships: Poster Sessions, Student Networking Luncheon, WiFi, Conference Bags, Conference Lanyards


Program and Web Advertising

About SPIE:

SPIE is an international society advancing an interdisciplinary approach to the science and application of light.

About the Society
The not-for-profit society advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth.

Keynote Speakers

Richard B. Gunderman

Indiana Univ. (United States)

Human beings are born with a remarkable visual apparatus, but even if all the parts – lens, retina, optic nerve, and so on – are present in working order, seeing remains at least in large part a learned skill. This is reflected in the fact that some people can see and understand things that others find meaningless or even fail to notice. One striking example is the radiology education of medical students and residents, who over the course of their training move from not knowing what they are looking at to quickly making complex diagnoses. In this session, we consider how seeing is learned and weigh the respective contributions of science, technology, and the arts in cultivating this remarkable human capacity. 

Richard Gunderman is chancellor’s professor of radiology, pediatrics, medical education, philosophy, liberal arts, philanthropy, and medical humanities and health studies at Indiana University. The author of over 600 articles and 10 books, he has received the highest teaching awards of his medical school, Indiana University, and the Association of American Medical Colleges. His latest book is, We Come to Life with Those We Serve.

Martin Pomper

The Johns Hopkins Univ. School of Medicine (United States)

Approximately 20 years ago in vivo molecular imaging as a unique discipline coalesced around a variety of modalities used to answer specific biological questions. Now in the era of precision medicine imaging ascends to a new level of relevance. Precision medicine leverages individual differences in genetics, environment and lifestyle to provide optimum care. While precision medicine is primarily thought of in genetic terms, providing information about whether an individual may harbor disease, precision imaging makes precision medicine actionable by uncovering the location of where disease may be present – or may soon be manifested. As molecularly targeted and precise therapies are increasingly adopted, imaging agents must follow suit by being equally precise to be useful in guiding management. In some cases existing imaging techniques and agents may not be up to the task of guiding emerging cancer therapies, as with anatomic imaging (CT or MR) for cytostatic therapeutics or standard molecular imaging (FDG-PET) for immunotherapy. Theranostic agents enable imaging and therapy concurrently, or in rapid succession, and are often precisely targeted. An array of precision imaging agents and theranostics is coming online to manage patients in new ways. In addition to providing a brief overview of imaging biomarkers for precision medicine, we will discuss specific examples – including theranostics – that are in the process of or will soon be clinically implemented for targeting prostate cancer and for reporting on immunotherapies. An important aspect of this work is that the agents provide sensitive, specific and quantitative information. 

Martin Pomper is the Henry N. Wagner, Jr. Professor of Radiology and Director of the Division of Nuclear Medicine and Molecular Imaging at Johns Hopkins Medical School. He received undergraduate, graduate (organic chemistry) and medical degrees from the University of Illinois at Urbana-Champaign. Postgraduate medical training was at Johns Hopkins, including internship on the Osler Medical Service, residencies in diagnostic radiology and nuclear medicine and a fellowship in neuroradiology. He is board-certified in diagnostic radiology and nuclear medicine. He has been on the Radiology faculty at Johns Hopkins since 1995, with several other joint appointments. His interests are in the development of new radiopharmaceuticals, optical probes and techniques for molecular imaging and therapy of cancer, central nervous system disease and other disorders. He is a member of the National Academy of Inventors and the National Academy of Medicine.

Martin Stumpe

Google Research (United States)

Rendering cancer diagnoses from biopsy slides involves challenging tasks for pathologists, such as detecting micro metastases in tissue biopsies, or distinguishing tumors from benign tissue that can look deceivingly similar. These tasks are typically very difficult for humans, and, consequently, over- and under-diagnoses are not uncommon, resulting in non-optimal treatment. Algorithmic approaches for pathology, on the other hand, face their own set of challenges in the form of gigapixel images, proprietary data formats, and low availability of digitized images let alone high quality labels. However, advances in deep learning, access to cloud based storage, and the recent FDA approval of the first whole slide image scanner for primary diagnosis now set the stage for a new era of digital pathology. This talk will discuss the potential of deep learning to improve the accuracy and availability of cancer diagnostics, and highlight some recent advances towards that goal. 

Martin Stumpe leads the Pathology project at Google Research. Before that, he worked on Google Street View for automatically building maps using machine learning. Prior to joining Google, Martin worked on NASA's Kepler Mission to detect extrasolar planets, and started a business with a computer vision tracking software, AnTracks. His background is in Physics, in which he graduated with a PhD at the Max-Planck-Institute in Goettingen, Germany, researching the molecular mechanisms of protein folding and stability, a topic that he continued during his postdoc research at Stanford University.


MORE events +

I Want to

Send me discounts and offers from hotels nearby
By Signing up you agree to User Agreement and Privacy Policy
I want to list my services